Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
Titel:
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
Auteur:
Holzgreve, Adrien Unterrainer, Marcus Calais, Jérémie Adams, Thaiza Oprea-Lager, Daniela E. Goffin, Karolien Lopci, Egesta Unterrainer, Lena M. Kramer, Kristina K. M. Schmidt-Hegemann, Nina-Sophie Casuscelli, Jozefina Stief, Christian G. Ricke, Jens Bartenstein, Peter Kunz, Wolfgang G. Mehrens, Dirk
Verschenen in:
European journal of nuclear medicine and molecular imaging